Back to Results
First PageMeta Content
Hepatology / Hepatitis / Virology / Hepatitis C / Hepatocellular carcinoma / Cirrhosis / Coinfection / Insulin resistance / Hepatitis C and HIV co-infection / Medicine / Biology / Health


Alimentary Pharmacology and Therapeutics The impact of hepatitis C burden: an evidence-based approach Z. M. Younossi*,†, F. Kanwal‡, S. Saab§, K. A. Brown¶, H. B. El-Serag‡, W. R. Kim**, A. Ahmed††, M. Kugel
Add to Reading List

Document Date: 2014-01-28 09:43:02

Open Document

File Size: 154,67 KB

Share Result on Facebook

City

Houston / Falls Church / Detroit / Rochester / /

Company

John Wiley & Sons Ltd / /

Country

France / Japan / China / Taiwan / Italy / United States / Spain / /

Currency

USD / /

/

Event

FDA Phase / Product Issues / /

Facility

Inova Fairfax Hospital / Henry Ford Hospital / University of California / Baylor College of Medicine Houston / University of Colorado / DeBakey Veterans Affairs Medical Center / Stanford University Medical Center / **Mayo Clinic / /

IndustryTerm

HCV therapy / Search terms / health utilities / consistent search criteria / treatment of HCV / HCV treatment / insurance database stratified / media thickening / computer software technology / health care systems / literature search guidelines / /

MedicalCondition

mental health disorders / related disease / HIV / HBV / HCV-related cirrhosis / rheumatic disorders / Non-Hodgkin’s lymphoma / cirrhosis / hepatitis B / diabetes outcomes / compensated HCV cirrhosis / G3 disease / carotid artery plaque / rheumatological diseases / liver cirrhosis / cirrhotic disease / hepatitis / baseline cirrhosis / chronic HCV infection / liver disease / cardiovascular diseases / hepatic decompensation / HCV RNA ) / 6 / recurrent disease / cholestatic liver disease / liver diseases / liver and infectious disease / chronic HCV / non-alcoholic fatty liver disease / consistently estimated disease / membrano-proliferative glomerulonephritis / stroke / noncirrhotic liver disease / diabetes / ischaemic heart disease / HCV / metabolic syndrome / HCV infection / chronic liver diseases / alcoholic cirrhosis / compensated cirrhosis / Diseases / coronary artery disease / infection / substance/ alcohol abuse / chronic infection / HCV-related cardiac disease / depression / Fibrosis / HCV RNA / vascular disease / lymphoma / severe insulin resistance / non-B hepatitis / specifically Non-Hodgkin’s B-cell lymphoma / hepatocellular cancer / hepatitis C / non-Hodgkin’s lymphoma and various extrahepatic rheumatological Aliment Pharmacol Ther / arthralgias / fatigue / HCV genotype 3 / primary biliary cirrhosis / HCV infections / HCVassociated disease / long-standing infection / congestive heart failure / insulin resistance / hypertension / both hepatic and extrahepatic diseases / disease / atherosclerosis / HCV cirrhosis / chronic liver disease / In addition to liver disease / cardiovascular disease / cholestatic hepatitis / SUMMARY Background Infection / carotid atherosclerosis / diabetes mellitus / vessel disease / advanced liver disease / extrahepatic diseases / Chronic hepatitis C / /

MedicalTreatment

immunosuppression / /

Organization

Center for Liver Diseases / University of Colorado / Denver / Stanford University Medical Center / Medicare / Division of Gastroenterology / Department of Medicine / S. C. Gordon¶ *Betty and Guy Beatty Center for Integrated Research / Henry Ford Hospital / US Preventative Services Task Force / Michael E. DeBakey Veterans Affairs Medical Center / Center for Liver Disease / Stanford University School of Medicine / Inova Fairfax Hospital / Centers for Disease Control and Prevention / Baylor College of Medicine Houston / Geffen School of Medicine / University of California / Los Angeles / US Department of Veterans Affairs / Stanford / /

Person

Z. M. Younossi / /

Position

general US population / /

Product

ribavirin / Pentax K-7 Digital Camera / El / HCV / fasting glucose / /

ProvinceOrState

Virginia / California / Colorado / Oregon / /

Technology

computer software technology / genotype / CAD / antibodies / transplantation / simulation / following liver transplantation / accelerated following liver transplantation / accelerated following liver transplantation.72 / /

SocialTag